BETA BLOCKER POST ACS IN PATIENTS WITH PRESERVED LEFT VENTRICULAR SYSTOLIC FUNCTION

Background: The benefit of beta-blockers in the management of patients with heart failure and left ventricular systolic dysfunction is established; however, their role in patients whose post-MI course is without such complications, recurrent ischemia, or arrhythmia is less established. We